Login / Signup

Genomic profiling of advanced cervical cancer to predict response to programmed death-1 inhibitor combination therapy: a secondary analysis of the CLAP trial.

Xin HuangMinjun HeHongyu PengChongjie TongZhimin LiuXiaolong ZhangYang ShaoDongqin ZhuJunli ZhangJiani C YinFan YangChunyan Lan
Published in: Journal for immunotherapy of cancer (2022)
NCT03816553.
Keyphrases
  • combination therapy
  • phase iii
  • study protocol
  • phase ii
  • clinical trial
  • single cell
  • copy number
  • randomized controlled trial
  • open label
  • gene expression